We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QFIN icon
1501
Qfin Holdings
QFIN
$1.61B
-159,238
Closed -$1.87M
QRVO icon
1502
Qorvo
QRVO
$8.74B
-13,065
Closed -$870K
RACE icon
1503
Ferrari
RACE
$72.5B
-9,444
Closed -$1.52M
RCKT icon
1504
Rocket Pharmaceuticals
RCKT
$394M
-11,566
Closed -$174K
RDFN
1505
DELISTED
Redfin
RDFN
-23,590
Closed -$424K
RDUS
1506
DELISTED
Radius Recycling
RDUS
-55,089
Closed -$1.44M
REAL icon
1507
The RealReal
REAL
$1.5B
-120,000
Closed -$3.47M
RF icon
1508
Regions Financial
RF
$26.8B
-115,325
Closed -$1.72M
RIGL icon
1509
Rigel Pharmaceuticals
RIGL
$750M
-3,149
Closed -$82K
RIO icon
1510
Rio Tinto
RIO
$164B
-581,323
Closed -$36.2M
RLJ icon
1511
RLJ Lodging Trust
RLJ
$1.69B
-135,548
Closed -$2.4M
RMD icon
1512
ResMed
RMD
$30.7B
-7,534
Closed -$919K
RNR icon
1513
RenaissanceRe
RNR
$13.4B
-22,504
Closed -$4.01M
ROG icon
1514
Rogers Corp
ROG
$2.4B
-10,797
Closed -$1.86M
RUSHA icon
1515
Rush Enterprises Class A
RUSHA
$6.22B
-30,191
Closed -$490K
SAH icon
1516
Sonic Automotive
SAH
$2.61B
-97,833
Closed -$2.28M
SAND
1517
DELISTED
Sandstorm Gold
SAND
-269,691
Closed -$1.5M
SB icon
1518
Safe Bulkers
SB
$774M
-30,625
Closed -$48K
SBRA icon
1519
Sabra Healthcare REIT
SBRA
$5.37B
-17,303
Closed -$341K
SCOR icon
1520
Comscore
SCOR
$109M
-12,871
Closed -$1.33M
SEIC icon
1521
SEI Investments
SEIC
$12.6B
-40,254
Closed -$2.26M
SEM
1522
DELISTED
Select Medical
SEM
-108,856
Closed -$931K
SFL icon
1523
SFL Corp
SFL
$1.61B
-105,692
Closed -$1.32M
SFNC icon
1524
Simmons First National
SFNC
$3.39B
-29,168
Closed -$678K
SHAK icon
1525
Shake Shack
SHAK
$2.87B
-6,815
Closed -$492K

Similar funds

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.